Repros Therapeutics Inc. News Headlines

RPRX 
$15.98
*  
0.28
 negative 
1.78%
Get RPRX Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

Repros Completes Enrollment for Androxal Study - Analyst Blog
4/15/2014 6:15:01 PM - Zacks.com

Repros Provides Proellex Update - Analyst Blog
3/18/2014 5:10:01 PM - Zacks.com

ATEC Sees Growth, FPRX Gets High-Five, RNA Walks The Talk, RPRX On The Move
3/18/2014 1:39:00 AM - RTT News

Repros Allowed To Conduct Phase 1, 2 Studies Of Oral Proellex - Quick Facts
3/17/2014 9:46:00 AM - RTT News

Narrower-than-Expected Q4 Loss at Repros - Analyst Blog
3/14/2014 9:50:01 AM - Zacks.com

Data on Repros' Androxal - Analyst Blog
2/11/2014 7:26:01 PM - Zacks.com

Repros Therapeutics (RPRX) Jumps: Stock Rises 6.1% - Tale of the Tape
2/10/2014 10:46:01 AM - Zacks.com

Repros Announces Additional Results From ZA-300 Six Month Study Of Androxal
2/10/2014 9:35:00 AM - RTT News

Repros Shares Soar After FDA Meeting - Analyst Blog
2/7/2014 11:27:01 AM - Zacks.com

Repros Meets With FDA To Discuss Data Requirements For Androxal
2/6/2014 4:59:00 AM - RTT News

Can the Rally in Repros Therapeutics (RPRX) Shares Continue? - Tale of the Tape
1/16/2014 7:43:01 AM - Zacks.com

Repros Continues to Gain on Androxal News - Analyst Blog
1/13/2014 6:00:01 PM - Zacks.com

Loss Narrows at Repros, Shares Down - Analyst Blog
11/11/2013 12:50:01 PM - Zacks.com

Update on Repros' Pipeline - Analyst Blog
11/6/2013 8:05:24 PM - Zacks.com

Androxal Makes Repros A Buy
11/2/2013 7:08:00 AM - Seeking Alpha

Insiders Buy Shares at Helix Energy and SunTrust Banks While Ruby Tuesday Sees a Sale
10/28/2013 9:50:00 AM - Minyanville

Update on Repros' Androxal - Analyst Blog
10/25/2013 6:07:15 PM - Zacks.com

Repros Continues to Climb - Analyst Blog
9/23/2013 4:45:01 PM - Zacks.com

Repros Climbs on Positive Androxal Data - Analyst Blog
9/18/2013 12:10:01 PM - Zacks.com

Market Wrap for Tuesday, September 17: Metals All Down, Repros Therapeutics Gives Back Mostly All Gains
9/17/2013 4:15:50 PM - Benzinga

Mid-Afternoon Market Update: Markets Topping Out as Berry Plastics Gets Crushed on Poor Guidance
9/17/2013 3:40:16 PM - Benzinga

Repros Therapeutics: Winning The Battle But Losing The War?
9/17/2013 8:52:00 AM - Seeking Alpha

Approval In Peyronie's Only Part Of The Auxilium Story
8/27/2013 10:21:00 AM - Seeking Alpha

Repros Reports Androxal Interim Data - Analyst Blog
8/21/2013 5:20:01 PM - Zacks.com

Loss Widens at Repros in Q2 - Analyst Blog
8/13/2013 10:45:01 AM - Zacks.com